A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob
- PMID: 11406768
- DOI: 10.1038/sj.gt.3301453
A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob
Abstract
The use of recombinant adenovirus (Ad) vectors containing genetically modified capsid proteins is an attractive strategy for achieving targeted gene transfer. The HI loop of the fiber knob is a promising candidate location for the incorporation of foreign ligands for achieving this goal. However, the method of constructing an Ad vector containing a foreign ligand in the HI loop of the fiber knob has proved difficult. In this study, we developed a simple system to construct fiber-modified vectors. To do this, a vector plasmid containing a complete E1/E3-deleted Ad type 5 genome and a unique Csp45I and/or ClaI site between positions 32679 and 32680 of the Ad genome (residues threonine-546 and proline-547 of the fiber protein) was constructed. Oligonucleotides corresponding to the Arg-Gly-Asp (RGD) or Asn-Gly-Arg (NGR)-containing peptide motif (as a model) and containing a Csp45I and/or ClaI recognition site, were ligated into the Csp45I and/or ClaI-digested plasmid. The foreign transgene expression cassette was inserted into the E1 deletion site of the vector plasmid and the fiber-mutant Ad vector was produced by transfection of the PacI-digested plasmid into 293 cells. The virus containing the RGD or NGR peptide on the fiber knob was able to infect human glioma cells, which do not express coxsackievirus and adenovirus receptor (CAR), one of the Ad virus receptors, about 100-1000 times more efficient than the virus containing wild-type fiber. This suggested that the mutant virus mediated CAR-independent cell entry pathway. The simplicity of this method allows not only for easy construction of fiber-mutant Ad vectors, but also for screening of the peptides that target the vector to the desired cells and tissues.
Similar articles
-
Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.Gene Ther. 2007 Feb;14(3):266-74. doi: 10.1038/sj.gt.3302859. Epub 2006 Sep 28. Gene Ther. 2007. PMID: 17006548
-
Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity.Gene Ther. 2007 Aug;14(15):1160-5. doi: 10.1038/sj.gt.3302969. Epub 2007 May 17. Gene Ther. 2007. PMID: 17508008
-
A system for the propagation of adenoviral vectors with genetically modified receptor specificities.Nat Biotechnol. 1999 May;17(5):470-5. doi: 10.1038/8647. Nat Biotechnol. 1999. PMID: 10331807
-
Biophysical targeting of adenovirus vectors for gene therapy.Curr Opin Mol Ther. 2000 Oct;2(5):524-31. Curr Opin Mol Ther. 2000. PMID: 11249755 Review.
-
[Technique for constructing recombinant adenovirus vectors and application for next generation vectors].Nihon Rinsho. 2000 Jul;58(7):1544-53. Nihon Rinsho. 2000. PMID: 10921338 Review. Japanese.
Cited by
-
Bacteriophage-derived vectors for targeted cancer gene therapy.Viruses. 2015 Jan 19;7(1):268-84. doi: 10.3390/v7010268. Viruses. 2015. PMID: 25606974 Free PMC article. Review.
-
Tumor necrosis factor alpha-gene therapy for an established murine melanoma using RGD (Arg-Gly-Asp) fiber-mutant adenovirus vectors.Jpn J Cancer Res. 2002 Apr;93(4):436-44. doi: 10.1111/j.1349-7006.2002.tb01275.x. Jpn J Cancer Res. 2002. PMID: 11985794 Free PMC article.
-
Combined p14ARF and Interferon-β Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation.Front Immunol. 2020 Oct 22;11:576658. doi: 10.3389/fimmu.2020.576658. eCollection 2020. Front Immunol. 2020. PMID: 33193370 Free PMC article.
-
Evaluation of transduction properties of an adenovirus vector in neonatal mice.Biomed Res Int. 2015;2015:685374. doi: 10.1155/2015/685374. Epub 2015 May 13. Biomed Res Int. 2015. PMID: 26075257 Free PMC article.
-
An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection.Vaccine. 2013 Oct 1;31(42):4834-40. doi: 10.1016/j.vaccine.2013.07.077. Epub 2013 Aug 9. Vaccine. 2013. PMID: 23933335 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical